AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS PR Newswire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on AMGN
    AMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
    9:51a ET March 5 '24 PR Newswire

    Amgen (NASDAQ:AMGN) will present at the 44th Annual TD Cowen Health Care Conference at 9:10 a.m. ET on Tuesday, March 5, 2024. Peter Griffith, executive vice president and chief financial officer at Amgen, and Paul Burton, senior vice president and chief medical officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

    The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

    Additional Information on Amgen.comTo provide further context, information and detail around our activities with respect to our obesity program, Amgen has established a website called "Amgen Perspectives in Obesity". Click here for more information: www.Amgen.com/obesity.

    AboutAmgenAmgenis committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

    Amgenfocuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980,Amgenhas grown to beone ofthe world'sleadingindependent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

    Amgenis one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME.

    For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn, Instagram, TikTok, YouTubeand Threads.

    CONTACT: Amgen, Thousand Oaks Jessica Akopyan, 805-440-5721 (media) Justin Claeys, 805-313-9775 (investors)

    https://mma.prnewswire.com/media/152881/amgen_logo.jpg

    https://c212.net/c/img/favicon.png?sn=LA48604&sd=2024-02-29

    View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-44th-annual-td-cowen-health-care-conference-302074910.html

    SOURCE Amgen

    https://rt.newswire.ca/rt.gif?NewsItemId=LA48604&Transmission_Id=202402291600PR_NEWS_USPR_____LA48604&DateId=20240229

    COMTEX_448770105/1005/2024-03-05T09:51:43

    Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Ph...
    4:01p ET May 2 '24 BusinessWire
    AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
    7:01a ET May 1 '24 PR Newswire
    AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTS
    4:00p ET April 29 '24 PR Newswire
    AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO T...
    9:00a ET April 26 '24 PR Newswire
    AMGEN PRESENTS NEW RESEARCH ON OTEZLA(R) (APREMILAST) AT AAD 2024
    12:20p ET March 9 '24 PR Newswire
    AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
    4:00p ET March 6 '24 PR Newswire
    AMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
    9:51a ET March 5 '24 PR Newswire
    AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO
    9:00a ET February 26 '24 PR Newswire
    AMGEN TO HOST CONFERENCE CALL ON RARE DISEASE
    4:00p ET February 19 '24 PR Newswire
    AMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIEN...
    4:00p ET February 9 '24 PR Newswire

    Market data provided by News provided by